English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

on diastolic pressure dipping. To the Editor: We appreciate the interest of Dr Sobiczewski and Dr Wirtwein in our study “Step Count is Associated With Lower Nighttime Systolic Blood Pressure and Increased Dipping.”1 This study, which included patients referred for ambulatory blood pressure (ABP) monitoring, shows that step count is associated with lower nighttime systolic blood pressures (BP) and increased systolic and diastolic BP dipping. In a secondary analysis, we showed that the step count increases from reverse dippers to extreme dippers using mean BP to categorize the participants’ dipping status. It is true that most clinical trials on the prognostic value of BP dipping have focused on systolic BP rather than mean or diastolic BP because, with age, there is a gradual shift from diastolic BP to systolic BP as predictors of coronary heart disease.2 In our study, which included young to elderly participants, replacing mean BP dipping by systolic or diastolic BP dipping to categorize dipping status did not change the association between step count and dipping categories (Table 1). It is true that ABP is not necessary to diagnose hypertension according to European Society of Hypertension guidelines. However, this is essentially for practical reasons: cost and availability. The prognosis value of ABP is undoubtedly more accurate than office BP,3,4 and some of the latest guidelines, such as those of the National Institute for Health and Clinical Excellence (NICE), have recommended a wider use of ABP.5 In this regard, we would like to emphasize that the prevalence of white coat hypertension and masked hypertension in our participants without antihypertensive treatment was 22% and 27%, respectively. Misclassifying patients may result in unnecessary treatments or failure to treat patients at risk. Data about secondary hypertension or the timing of drug taking, which are known to affect BP dipping, were not recorded in this study. An influence of these variables on BP dipping can therefore not be excluded. Blockers of the renin angiotensin system, betablockers, calcium channel blockers, and diuretics were not associated with BP dipping. However, the study was not designed to answer this specific question and may therefore not be sufficiently powered to resolve this issue. DiSCLoSURe

Response to "Assessment of Blood Pressure Dipping: Is the Evaluation Method Important?"